Marshall Wace LLP Purchases 56,192 Shares of Owens & Minor, Inc. (NYSE:OMI)

Marshall Wace LLP raised its position in shares of Owens & Minor, Inc. (NYSE:OMI - Free Report) by 321.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 73,692 shares of the company's stock after acquiring an additional 56,192 shares during the quarter. Marshall Wace LLP owned approximately 0.10% of Owens & Minor worth $963,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Gabelli Funds LLC grew its stake in shares of Owens & Minor by 81.1% in the 4th quarter. Gabelli Funds LLC now owns 326,000 shares of the company's stock valued at $4,261,000 after buying an additional 146,000 shares during the period. Guggenheim Capital LLC acquired a new stake in Owens & Minor in the fourth quarter valued at approximately $166,000. Optimize Financial Inc acquired a new stake in shares of Owens & Minor in the 4th quarter valued at $184,000. Sterling Capital Management LLC boosted its position in shares of Owens & Minor by 758.3% during the 4th quarter. Sterling Capital Management LLC now owns 2,060 shares of the company's stock worth $27,000 after acquiring an additional 1,820 shares in the last quarter. Finally, Kennedy Capital Management LLC increased its stake in Owens & Minor by 15.5% in the fourth quarter. Kennedy Capital Management LLC now owns 1,216,859 shares of the company's stock valued at $15,904,000 after purchasing an additional 163,184 shares during the last quarter. Hedge funds and other institutional investors own 98.04% of the company's stock.

Analyst Ratings Changes

Several analysts have recently weighed in on OMI shares. UBS Group reduced their target price on Owens & Minor from $25.00 to $13.00 and set a "buy" rating for the company in a report on Thursday, February 13th. Citigroup cut their target price on Owens & Minor from $13.00 to $11.00 and set a "buy" rating for the company in a research note on Thursday, April 17th. Robert W. Baird upped their target price on shares of Owens & Minor from $10.00 to $11.00 and gave the stock a "neutral" rating in a research report on Monday, March 3rd. Finally, JPMorgan Chase & Co. dropped their target price on shares of Owens & Minor from $14.00 to $10.00 and set an "underweight" rating for the company in a report on Monday, March 10th. Two analysts have rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Hold" and a consensus target price of $12.50.

Owens & Minor Stock Down 1.2 %

Shares of NYSE:OMI traded down $0.10 during trading on Tuesday, reaching $8.08. 232,702 shares of the company traded hands, compared to its average volume of 1,577,111. The company has a quick ratio of 0.45, a current ratio of 1.09 and a debt-to-equity ratio of 2.11. Owens & Minor, Inc. has a 1-year low of $6.07 and a 1-year high of $21.02. The firm has a fifty day simple moving average of $8.25 and a 200 day simple moving average of $10.94. The firm has a market cap of $624.22 million, a P/E ratio of -12.43, a price-to-earnings-growth ratio of 0.20 and a beta of 1.38.

Owens & Minor (NYSE:OMI - Get Free Report) last released its quarterly earnings data on Friday, February 28th. The company reported $0.55 EPS for the quarter, topping analysts' consensus estimates of $0.53 by $0.02. Owens & Minor had a negative net margin of 0.46% and a positive return on equity of 14.60%. The company had revenue of $2.70 billion during the quarter, compared to the consensus estimate of $2.68 billion. During the same period last year, the firm earned $0.69 EPS. The firm's revenue for the quarter was up 1.5% compared to the same quarter last year. Analysts anticipate that Owens & Minor, Inc. will post 1.51 earnings per share for the current fiscal year.

Owens & Minor announced that its Board of Directors has approved a share repurchase program on Friday, February 28th that authorizes the company to buyback $100.00 million in shares. This buyback authorization authorizes the company to repurchase up to 13.6% of its shares through open market purchases. Shares buyback programs are usually an indication that the company's leadership believes its shares are undervalued.

Insider Activity

In other Owens & Minor news, major shareholder Coliseum Capital Management, L acquired 225,000 shares of the business's stock in a transaction that occurred on Wednesday, April 9th. The shares were acquired at an average cost of $7.39 per share, for a total transaction of $1,662,750.00. Following the completion of the acquisition, the insider now directly owns 11,482,955 shares of the company's stock, valued at approximately $84,859,037.45. This represents a 2.00 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In the last ninety days, insiders bought 2,718,412 shares of company stock valued at $24,495,308. Company insiders own 3.69% of the company's stock.

Owens & Minor Company Profile

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.